X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs FDC LTD. - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER FDC LTD. PFIZER/
FDC LTD.
 
P/E (TTM) x 32.4 18.4 176.2% View Chart
P/BV x 4.8 4.1 115.2% View Chart
Dividend Yield % 0.7 1.1 62.5%  

Financials

 PFIZER   FDC LTD.
EQUITY SHARE DATA
    PFIZER
Mar-18
FDC LTD.
Mar-14
PFIZER/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs2,365144 1,648.1%   
Low Rs1,62579 2,057.0%   
Sales per share (Unadj.) Rs430.347.6 904.6%  
Earnings per share (Unadj.) Rs78.77.6 1,034.3%  
Cash flow per share (Unadj.) Rs93.29.0 1,034.2%  
Dividends per share (Unadj.) Rs20.002.25 888.9%  
Dividend yield (eoy) %1.02.0 49.6%  
Book value per share (Unadj.) Rs586.547.5 1,233.8%  
Shares outstanding (eoy) m45.75177.83 25.7%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.62.3 198.2%   
Avg P/E ratio x25.314.6 173.4%  
P/CF ratio (eoy) x21.412.3 173.4%  
Price / Book Value ratio x3.42.3 145.3%  
Dividend payout %25.429.6 85.9%   
Avg Mkt Cap Rs m91,27119,784 461.3%   
No. of employees `0002.6NA-   
Total wages/salary Rs m3,1431,221 257.5%   
Avg. sales/employee Rs Th7,484.8NM-  
Avg. wages/employee Rs Th1,195.0NM-  
Avg. net profit/employee Rs Th1,369.1NM-  
INCOME DATA
Net Sales Rs m19,6858,459 232.7%  
Other income Rs m1,143394 290.4%   
Total revenues Rs m20,8288,852 235.3%   
Gross profit Rs m5,0032,070 241.7%  
Depreciation Rs m663249 266.0%   
Interest Rs m431 13.5%   
Profit before tax Rs m5,4792,184 250.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-225 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,878606 310.2%   
Profit after tax Rs m3,6011,353 266.1%  
Gross profit margin %25.424.5 103.8%  
Effective tax rate %34.327.7 123.6%   
Net profit margin %18.316.0 114.3%  
BALANCE SHEET DATA
Current assets Rs m24,1674,355 554.9%   
Current liabilities Rs m9,5441,792 532.6%   
Net working cap to sales %74.330.3 245.1%  
Current ratio x2.52.4 104.2%  
Inventory Days Days5544 123.9%  
Debtors Days Days2925 116.4%  
Net fixed assets Rs m9,5143,025 314.5%   
Share capital Rs m458179 256.2%   
"Free" reserves Rs m26,3758,243 320.0%   
Net worth Rs m26,8328,453 317.4%   
Long term debt Rs m2511 233.6%   
Total assets Rs m36,90010,557 349.5%  
Interest coverage x1,305.571.4 1,828.1%   
Debt to equity ratio x00 73.6%  
Sales to assets ratio x0.50.8 66.6%   
Return on assets %9.813.1 74.5%  
Return on equity %13.416.0 83.8%  
Return on capital %20.423.5 86.8%  
Exports to sales %013.3 0.0%   
Imports to sales %03.3 0.0%   
Exports (fob) Rs mNA1,126 0.0%   
Imports (cif) Rs mNA283 0.0%   
Fx inflow Rs m221,146 2.0%   
Fx outflow Rs m1,489355 419.0%   
Net fx Rs m-1,466791 -185.4%   
CASH FLOW
From Operations Rs m3,3181,485 223.4%  
From Investments Rs m-2,383-620 384.7%  
From Financial Activity Rs m-1,104-753 146.6%  
Net Cashflow Rs m-169113 -149.4%  

Share Holding

Indian Promoters % 0.0 68.9 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 4.7 159.6%  
FIIs % 4.9 7.5 65.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 19.0 124.7%  
Shareholders   85,207 23,730 359.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   PIRAMAL ENTERPRISES  ABBOTT INDIA  PLETHICO PHARMA  DR. REDDYS LAB  GSK PHARMA  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Finish Flat; IT and Pharma Stocks Witness Selling(Closing)

Share markets in India ended their trading session on a flattish note. Sectoral indices ended on a mixed note with stocks in the IT sector and pharma sector witnessing most of the selling pressure.

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY19); Net Profit Up 74.5% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, FDC LTD. has posted a net profit of Rs 511 m (up 74.5% YoY). Sales on the other hand came in at Rs 3 bn (up 16.7% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

PFIZER Announces Quarterly Results (1QFY19); Net Profit Up 60.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, PFIZER has posted a net profit of Rs 918 m (up 60.6% YoY). Sales on the other hand came in at Rs 5 bn (up 18.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are You Among The 35% Parents Who Will Not Be Able To Finance Their Child's Future?(Outside View)

Nov 1, 2018

PersonalFN explains the importance of being prepared for your child's future.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Nov 14, 2018 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS